CHI3L1 and neoplasm: A meta-analysis on CHI3L1 included 234 EC patients and 300 normal individuals, showing that 74% of EC patients had elevated CHI3L1 levels, indicating that CHI3L1 is indeed a valuable tumor marker for EC [150].